- Home
- Publications
- Publication Search
- Publication Details
Title
Pemetrexed for the treatment of non-small cell lung cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 14, Issue 11, Pages 1545-1558
Publisher
Informa Healthcare
Online
2013-05-17
DOI
10.1517/14656566.2013.802774
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thymidylate Synthase and Folyl-Polyglutamate Synthase Are Not Clinically Useful Markers of Response to Pemetrexed in Patients with Malignant Pleural Mesothelioma
- (2013) Daniel E. Schwed Lustgarten et al. Journal of Thoracic Oncology
- Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study
- (2012) M. Kreuter et al. ANNALS OF ONCOLOGY
- Dose escalation study of carboplatin–pemetrexed followed by maintenance pemetrexed for elderly patients with advanced nonsquamous nonsmall-cell lung cancer
- (2012) A. Tamiya et al. ANNALS OF ONCOLOGY
- Pemetrexed for Previously Treated Patients with Non-Small Cell Lung Cancer and Differences in Efficacy according to Thymidylate Synthase Expression
- (2012) Satoshi Igawa et al. CHEMOTHERAPY
- Pemetrexed Therapy in Elderly Patients With Good Performance Status: Analysis of Two Phase III Trials of Patients With Nonsquamous Non–Small-Cell Lung Cancer
- (2012) Cesare Gridelli et al. Clinical Lung Cancer
- Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
- (2012) Nitzan Gonen et al. DRUG RESISTANCE UPDATES
- Management of Non-Small Cell Lung in Cancer Patients with Stable Disease
- (2012) Francesco Grossi DRUGS
- Effectiveness and safety of pemetrexed-based doublet versus pemetrexed alone as second-line treatment for advanced non-small-cell lung cancer: a systematic review and meta-analysis
- (2012) Wei-Xiang Qi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non–Small-Cell Lung Cancer
- (2012) Luis G. Paz-Ares et al. JOURNAL OF CLINICAL ONCOLOGY
- Pemetrexed Versus Pemetrexed and Carboplatin As Second-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Results of the GOIRC 02-2006 Randomized Phase II Study and Pooled Analysis With the NVALT7 Trial
- (2012) Andrea Ardizzoni et al. JOURNAL OF CLINICAL ONCOLOGY
- Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial
- (2012) Luis Paz-Ares et al. LANCET ONCOLOGY
- Maintenance treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
- (2012) Cesare Gridelli et al. LUNG CANCER
- Pemetrexed plus Platinum as the First-Line Treatment Option for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
- (2012) Ming Li et al. PLoS One
- Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan
- (2011) Myung-Ju AHN et al. Asia-Pacific Journal of Clinical Oncology
- AVAPERL (MO22089): Final Efficacy Outcomes for Patients (pts) With Advanced Non-squamous Non-small Cell Lung Cancer (nsNSCLC) Randomised to Continuation Maintenance (mtc) with Bevacizumab (bev) or Bev + Pemetrexed (pern) After First-line (1L) Bev-cisplatin (cis)-pem Treatment (Tx)
- (2011) F Barlesi et al. EUROPEAN JOURNAL OF CANCER
- Pharmacokinetic evaluation of pemetrexed
- (2011) Jens Benn Sørensen Expert Opinion on Drug Metabolism & Toxicology
- Expression and pharmacological inhibition of thymidylate synthase and Src kinase in nonsmall cell lung cancer
- (2011) Paolo Ceppi et al. INTERNATIONAL JOURNAL OF CANCER
- Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Richard H. de Boer et al. JOURNAL OF CLINICAL ONCOLOGY
- A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer
- (2011) José Rodrigues-Pereira et al. Journal of Thoracic Oncology
- Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed
- (2011) Chung-Yu Chen et al. LUNG CANCER
- Phase II study of pemetrexed plus oxaliplatin for platinum-resistant advanced or metastatic non-small cell lung cancer patients
- (2011) Dae Ho Lee et al. MEDICAL ONCOLOGY
- Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways
- (2011) Tsung-Ying Yang et al. MOLECULAR CARCINOGENESIS
- PCN36 COST ANALYSIS, SAFETY, AND EFFICACY OF PEMETREXED/CISPLATIN COMPARED WITH BEVACIZUMAB/GEMCITABINE/CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED NON-SQUAMOUS NSCLC IN RUSSIA
- (2011) P. Davey et al. VALUE IN HEALTH
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pemetrexed Safety and Pharmacokinetics in Patients with Third-Space Fluid
- (2010) N. J. Dickgreber et al. CLINICAL CANCER RESEARCH
- Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients
- (2010) Guan-Zhong Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Phase II, Double-Blinded, Randomized Study of Enzastaurin Plus Pemetrexed as Second-Line Therapy in Patients with Advanced Non-small Cell Lung Cancer
- (2010) Alberto Chiappori et al. Journal of Thoracic Oncology
- Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer
- (2010) Mark A. Socinski et al. Journal of Thoracic Oncology
- Pemetrexed with or without Matuzumab as Second-Line Treatment for Patients with Stage IIIB/IV Non-small Cell Lung Cancer
- (2010) Joan H. Schiller et al. Journal of Thoracic Oncology
- Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy
- (2010) Giovanni Giuliani et al. LUNG CANCER
- A phase II study of pemetrexed and carboplatin as a salvage therapy for platinum-pretreated patients with non-small cell lung cancer
- (2010) Hyeong Su Kim et al. LUNG CANCER
- Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
- (2010) Yaping Xu et al. LUNG CANCER
- Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
- (2009) Francesca Russo et al. BMC CANCER
- Therapeutics by Cytotoxic Metabolite Accumulation: Pemetrexed Causes ZMP Accumulation, AMPK Activation, and Mammalian Target of Rapamycin Inhibition
- (2009) Alexandra C. Racanelli et al. CANCER RESEARCH
- Treatment Rationale and Study Design for the PointBreak Study: A Randomized, Open-label Phase III Study of Pemetrexed/Carboplatin/Bevacizumab Followed by Maintenance Pemetrexed/Bevacizumab Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer
- (2009) Jyoti D. Patel et al. Clinical Lung Cancer
- PROCLAIM: A Phase III Study of Pemetrexed, Cisplatin, and Radiation Therapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiation Therapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Locally Advanced Stage III Non–Small-Cell Lung Cancer of Other than Predominantly Squamous Cell Histology
- (2009) Everett E. Vokes et al. Clinical Lung Cancer
- Phase II Study of Pemetrexed and Carboplatin Plus Bevacizumab With Maintenance Pemetrexed and Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer
- (2009) Jyoti D. Patel et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer
- (2009) Egbert F. Smit et al. JOURNAL OF CLINICAL ONCOLOGY
- Colorectal Hepatic Metastases: Adjuvant Chemotherapy and Survival
- (2009) David J. Gallagher et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer
- (2009) Bjørn H. Grønberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study
- (2009) Tudor Ciuleanu et al. LANCET
- A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer
- (2009) Giorgio V. Scagliotti et al. LUNG CANCER
- Potential Treatment Options After First-Line Chemotherapy for Advanced NSCLC: Maintenance Treatment or Early Second-Line?
- (2009) C. Gridelli et al. ONCOLOGIST
- A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
- (2008) M. H. Cullen et al. ANNALS OF ONCOLOGY
- Efficacy and Safety of Two Doses of Pemetrexed Supplemented with Folic Acid and Vitamin B12 in Previously Treated Patients with Non-Small Cell Lung Cancer
- (2008) Y. Ohe et al. CLINICAL CANCER RESEARCH
- Identifying an optimum treatment strategy for patients with advanced non-small cell lung cancer
- (2008) Francesco Grossi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Evidence for Second- and Third-Line Treatment Options in Advanced Non-Small Cell Lung Cancer
- (2008) F. de Marinis et al. ONCOLOGIST
- Pemetrexed single agent in previously treated non-small cell lung cancer: A multi-institutional observational study
- (2007) Alessandra Bearz et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started